(Q49022015)

English

Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.

scientific article published on 8 January 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

0 references

NΩ-nitro-L-arginine methyl ester

1 reference

ChEBI release 2020-05-28

Anisha A. Gupte

10

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Dale J. Hamilton

object named as

Dale J Hamilton

1

0 references

author name string

Aijun Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Shumin Li

3

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Tram N Cao

4

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Jessie A Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Indira Vedula

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Andrea M Cordero-Reyes

7

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Keith A Youker

8

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Guillermo Torre-Amione

9

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

publication date

8 January 2016

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

310

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

6

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

H667-80

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Mitochondrial dysfunction in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Catabolism in chronic heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Nitric oxide synthases in heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Freshly isolated mitochondria from failing human hearts exhibit preserved respiratory function

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Left ventricular hypertrophy and angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

lumi: a pipeline for processing Illumina microarray

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Mitochondrial injury and dysfunction in hypertension-induced cardiac damage

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Importance of suitable reference gene selection for quantitative real-time PCR: special reference to mouse myocardial infarction studies

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

The role of heart rate in the modulation of the decreased cardiac output induced by acute nitric oxide synthesis inhibition in anaesthetized dogs.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Modulation of the renin-angiotensin-aldosterone system in heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Oxidative capacity in failing hearts

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Mechanical unloading promotes myocardial energy recovery in human heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

High-fat feeding-induced hyperinsulinemia increases cardiac glucose uptake and mitochondrial function despite peripheral insulin resistance

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Defective DNA replication impairs mitochondrial biogenesis in human failing hearts

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Small animal models of heart failure: development of novel therapies, past and present

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Role of nitric oxide in the renin and heart rate responses to beta-adrenergic stimulation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Impact of anesthesia on cardiac function during echocardiography in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Aldosterone and arterial hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Energetics and metabolism in the failing heart: important but poorly understood

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Mitochondrial formation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Angiotensin II and oxidative stress in the failing heart

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00746.2015

21 January 2018

Identifiers

10.1152/AJPHEART.00746.2015

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 February 2018

http://europepmc.org/abstract/MED/26747502

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49022015&oldid=1291963637"